1 terminated, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
Follow Paroxysmal Atrial Fibrillation: new trials by email Literature Review of Paroxysmal Atrial Fibrillation trials Research Report on Paroxysmal Atrial Fibrillation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation endomyocardial BT injection - Paroxysmal Atrial Fibrillation | Phase 1 | Unknown | Meshalkin Research Institute of Pathology of Circulation | 30 | 2013-06-01 | 2015-09-23 |
| Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation OPC-108459, Placebo - Atrial Fibrillation, Paroxysmal Atrial Fibrillation | Phase 1 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 40 | 2011-11-01 | 2017-04-10 |
Arrhythmias, Cardiac (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Meshalkin Research Institute of Pathology of Circulation (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
Germany (1) · Italy (1) · Netherlands (1) · Russia (1) · Spain (1) · United Kingdom (1) · United States (1)